Trials / Completed
CompletedNCT00943098
Evaluation of the Efficacy and Safety of Diclofenac HPBCD 75mg/ml in Treatment of Pain Following Dental Surgery
Efficacy and Safety of a Single s.c. Diclofenac HPBCD 75mg/1ml Injection as Compared to a Single i.m. Voltarol® 75mg/3ml, in the Treatment of Acute Moderate-to-severe Post-surgical Pain Following Dental Surgery (Impacted 3rd Molar Removal).
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 142 (actual)
- Sponsor
- IBSA Institut Biochimique SA · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The present study is aimed at demonstrating the therapeutic equivalence of diclofenac HPBCD 75mg/1ml s.c. with the marketed reference product, Voltarol® 75mg/3ml i.m. in the treatment of acute moderate-to-severe pain after dental impaction surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diclofenac HPBCD s.c. 75mg/ml | 1 single injection at day of dental surgical extraction |
| DRUG | Voltarol 75mg/3ml i.m. | 1 single injection at day of dental surgical extraction |
Timeline
- Start date
- 2009-09-01
- Primary completion
- 2010-03-01
- Completion
- 2010-05-01
- First posted
- 2009-07-22
- Last updated
- 2013-01-28
- Results posted
- 2013-01-28
Locations
3 sites across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT00943098. Inclusion in this directory is not an endorsement.